Form D · Biotechnology
Artielle ImmunoTherapeutics Inc
Tigard, OR · CIK 0001298528
Offering snapshot reported Sep 9, 2010 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 23, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2010 | Initial | $100,000 | No comparison | 5 | SEC filing |
| Apr 13, 2010 | Initial | $185,740 | No comparison | 5 | SEC filing |
| Oct 1, 2009 | Initial | $709,828 | No comparison | 6 | SEC filing |
| Aug 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-147489
1) Convertible Promissory Notes, the underlying shares of Preferred Stock and Common Stock isued on conversion thereof: 2) Common Stock Warrants and the underlying shares of Common Stock issuable upon exercise.
Source: Form D, filed Sep 9, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shahab Fatheazam | Director |
| Adolph J. Ferro | Director, Executive |
| Peter Mc Williams | Director |
| J. Brock Metcalf | Director |
| Gilbert N. Miller | Executive |
| Paul Quadros | Director |
| Allan Wolfe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9020 Sw Washington Square Road Suite 450
Tigard, OR, 97223
Tigard, OR, 97223